Summer 2009
Release of new generics offers savings opportunities
During 2009 and 2010, 25 brand-name drugs are scheduled to become available in their generic form. The introduction of these generics promises to provide substantial out-of-pocket savings for users. Keep in mind that a generic drug contains the same active ingredients in the same dosage form as a brand-name drug. All generic drugs are approved by the federal Food and Drug Administration (FDA) as safe and effective.
Not all brand-name drugs have exact generic equivalents, but there may be effective generic alternatives within the same therapeutic class.
We encourage our members to use generic medications. “Generic alternatives to high-priced branded drugs help increase adherence to prescribed drug therapies and improve health care, while providing value to cost-conscious consumers and businesses,” said John Frick, R.Ph., director, pharmacy initiative for the Blue Cross and Blue Shield Association.1 Our online tool for members, MyBlueServiceSM, includes a shopping tool to compare prescription drug prices from selected pharmacies. This allows members to find the least expensive, convenient location to fill their prescriptions.
The Pharmacy page under the Physicians & Providers section of our website, www.bcbsfl.com, contains BCBSF Medication Guides and updates.
The table below reflects a summary of the generic drugs that have or are scheduled to become available during 2009.
Brand Drug | Generic Name | * 2009 Generic Availability Date: | Used to treat: |
Depakote ER | divalproex ER | January | Seizures |
Topamax | topiramate | March | Seizures |
Casodex | bicalutamide | April | Prostate Cancer |
Cellcept | mycophenolate - mofetil | May | Immune System |
Seasonique | levonorgestrel - ethinyl estradiol | May | Contraception |
Alphagan P | brimonidine tartrate ophthalmic | September | Glaucoma |
Prandin | repaglinide | September | Diabetes |
Acular | ketorolac tromethamine ophthalmic | November | Eye Pain |
FemHRT | ethinyl estradiol - norethindrone acetate | November | Hormone Deficiency |
Prevacid | lansoprazole | November | Acid Reflux/Heartburn |
Sanctura | trospium | November | Overactive Bladder |
Valtrex | valacyclovir | December | Infection |
Example Cost Savings
Depakote ER | Retail 30 day supply: | $100.85 |
divalproex ER | Retail 30 day supply: | $75.20 |
| Potential Yearly Savings= | $307.80 |
Source: MyRxHealth.com *All dates are subject to change based on FDA approval process and generic manufacturers involved 1 Source: BCBSA April 2009 press release |
Author:
Online Editor:
Online Medical Reviewer:
Date Last Reviewed:
5/26/2009
Date Last Modified:
5/26/2009